+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Altimmune - logo

Altimmune is an immunotherapeutic biotechnology company that develops immunotherapeutic products and vaccines to address public health and biodefense needs. It offers NasoVAX, HepTcell, NasoShield and Oncosyn. The company also develops products for use in companion and commercial livestock and offers immunotherapeutic products for various disease indications. The company was founded in 1997 and is based in Gaithersburg, Maryland with operating sites in the UK and France.

Pandemic Influenza - Global Clinical Trials Review, H2, 2021 - Product Thumbnail Image

Pandemic Influenza - Global Clinical Trials Review, H2, 2021

  • Clinical Trials
  • September 2021
  • 121 Pages
  • Global
From
Coronavirus Disease 2019 (COVID-19) - Pipeline Review, H2 2020 - Product Thumbnail Image

Coronavirus Disease 2019 (COVID-19) - Pipeline Review, H2 2020

  • Drug Pipelines
  • July 2020
  • 3207 Pages
  • Global
From
Anthrax - Pipeline Review, H2 2020 - Product Thumbnail Image

Anthrax - Pipeline Review, H2 2020

  • Drug Pipelines
  • July 2020
  • 126 Pages
  • Global
From
Toll Like Receptor 8 (CD288 or TLR8) - Pipeline Review, H2 2019 - Product Thumbnail Image

Toll Like Receptor 8 (CD288 or TLR8) - Pipeline Review, H2 2019

  • Drug Pipelines
  • December 2019
  • 84 Pages
  • Global
From
Seasonal Influenza Global Clinical Trials Review, H1, 2020 - Product Thumbnail Image

Seasonal Influenza Global Clinical Trials Review, H1, 2020

  • Clinical Trials
  • June 2020
  • 159 Pages
  • Global
From
Altimmune Inc (ALT:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry - Product Thumbnail Image

Altimmune Inc (ALT:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry

  • Company Profile
  • December 2023
  • 89 Pages
From
Comprehensive Report on Altimmune Inc, including SWOT, PESTLE and Business Model Canvas - Product Thumbnail Image

Comprehensive Report on Altimmune Inc, including SWOT, PESTLE and Business Model Canvas

  • SWOT Analysis
  • August 2023
  • 90 Pages
From
Loading Indicator